PHILOGEN S.P.A.
50Patents
46Active
50Granted
52Portfolio score
Filing activity: May 23, 1997 → Oct 3, 2023 · 11 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8404814B2 | Anti-EDB antibody-targeted IL-10 cytokine for therapy of rheumatoid arthritis | Chemistry; Metallurgy | 16 | Active |
| US7273924B1 | Antibodies to the ED-B domain of fibronectin, their construction and uses | Human Necessities | 13 | Expired |
| US10308696B2 | IL2 and TNF immunoconjugates | Chemistry; Metallurgy | 12 | Active |
| US8623373B2 | Compositions and methods for treatment of angiogenesis in pathological lesions | Chemistry; Metallurgy | 10 | Expired |
| US8222377B2 | Antigen associated with rheumatoid arthritis | Chemistry; Metallurgy | 10 | Active |
| US8263041B2 | Antigen associated with the neovasculature of tumour metastases | Chemistry; Metallurgy | 9 | Active |
| US8455625B2 | Fusion protein of antibody L19 against fibronectin ED-B and interleukin 12 | Chemistry; Metallurgy | 9 | Active |
| US7968685B2 | Antibodies against Tenascin-C | Chemistry; Metallurgy | 9 | Active |
| US8481684B2 | Antigen associated with the neovasculature of tumour metastases | Chemistry; Metallurgy | 8 | Active |
| US7851599B2 | Combination of an anti-ED—B fibronectin domain antibody—IL-2 fusion protein and gemcitabine | Chemistry; Metallurgy | 7 | Active |
| US9181347B2 | Antigen associated with the neovasculature of tumour metastases | Chemistry; Metallurgy | 3 | Active |
| US8703143B2 | Antibodies of the ED-B domain of fibronectin, their construction and uses | Human Necessities | 3 | Active |
| US8679488B2 | Targeting of bone marrow neovasculature | Chemistry; Metallurgy | 3 | Active |
| US9580485B2 | IL-12 immunoconjugate | Emerging Cross-Sectional Technologies | 3 | Active |
| US9198979B2 | Thiazolidine linker for the conjugation of drugs to antibodies | Human Necessities | 3 | Active |
| US9695232B2 | Anti-ED-A immunoconjugates for inflammatory bowel disease | Chemistry; Metallurgy | 2 | Active |
| US9527907B2 | Antigens associated with endometriosis, psoriatic arthritis and psoriasis | Chemistry; Metallurgy | 2 | Active |
| US10195253B2 | Immunocytokine combination therapy | Chemistry; Metallurgy | 2 | Active |
| US9896503B2 | Antigen associated with the neovasculature of tumour metastases | Chemistry; Metallurgy | 2 | Active |
| US8784824B2 | Compositions and methods for treatment of angiogenesis in pathological lesions | Chemistry; Metallurgy | 2 | Active |
| US8491906B2 | Selective targeting of tumor vasculature using antibody molecules | Chemistry; Metallurgy | 1 | Active |
| US9096670B2 | Antibodies of the ED-B domain of fibronectin, their construction and uses | Human Necessities | 1 | Active |
| US9556257B2 | Antigen associated with rheumatoid arthritis | Chemistry; Metallurgy | 1 | Active |
| US11872288B2 | TNF-alpha immunoconjugate therapy for the treatment of brain tumors | Chemistry; Metallurgy | 1 | Active |
| US11351257B2 | Antibody compositions | Chemistry; Metallurgy | 1 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.